Tag: life sciences
-
Company Forms to Treat Vaginal Microbial Disorders
A new enterprise has launched to develop live microbial treatments for urinary tract infections and other diseases originating in vaginal bacterial communities.
-
Nanotech Vaccine Aids Melanoma Immunotherapy
A vaccine made with nanoscale peptide particles can prevent the occurrence of melanoma in lab mice, and treat the condition when combined with other drugs.
-
A.I. Finding Cancer Treatments in Generic Drugs
An organization seeking cancer treatments in off-patent generic drugs is partnering with a life science analytics company using artificial intelligence for drug discovery.
-
Algorithm Devised for Fast Heart Rhythm Screening
A machine-learning algorithm used with results from a standard electrocardiogram, is quickly able to detect irregular heart rhythms, a process that often takes much longer.
-
Heart Components Produced with 3-D Printing
Researchers developed techniques for accurate three-dimensional printing of human heart elements with bio-inks containing the cellular framework on which tissue can grow.
-
Industry-Academic Team Studies Myelin Renewal
Researchers are studying techniques for blocking proteins that damage myelin, the protective coating on nerve cells, as occurs in multiple sclerosis and other diseases.
-
Smart Watch, A.I. Analyzing Human Emotions
A study is underway mapping human emotions with data collected by smart watches and analyzed with an app powered by artificial intelligence.
-
Protein-Eluding Scaffolds Help Grow New Blood Vessels
A polymer frame infused with proteins that stimulate immune cells encourages growth of new blood vessels in lab mice with peripheral artery disease.
-
Once-a-Month Contraceptive Pill Being Developed
A company specializing in long-term release of drugs is receiving a foundation grant to develop a contraceptive pill for women that works for weeks at a time.
-
Hearing Loss Cell Therapy Licensed in $625M Deal
A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma.